ivx - good coverage in bio news texas, page-3

twigman
I am taking the news that FDA put on hold on it and then released it in a positive way.
couple of other news coverage as below:
http://www.pharmabiz.com/NewsDetails.aspx?aid=80505&sid=2

http://www.4-traders.com/INVION-LTD-11401230/news/Invion-Ltd--FDA-clears-path-for-ldquoSmoking-Cessationrdquo-clinical-trial-of-INV102-nadolol-17850166/

"
Invion Chief Medical Officer, Dr Mitchell Glass said, "The FDA took the unusual step of changing our reviewing division to DAAAP after study initiation, which then placed us on clinical hold. Questions raised by the DAAAP were resolved by aligning titration criteria and dosing with our asthma study. These changes will enable sites to recruit and treat our targeted COPD patient population which is in dire need of successfully quitting smoking."
"
the words "resolved by aligning titration criteria and dosing with our asthma study." look promising for me.

I am putting my faith in Greg & his excellent team. Hopefully am not wrong:-)

ps: always DYOR. not a financial advise.